Entering text into the input field will update the search result below

Amgen Q1 revenues up 2%; earnings up 12%; cash flow up 14%; earnings guidance raised; shares up 1% after hours

Apr. 24, 2018 4:16 PM ETAmgen Inc. (AMGN) StockBy: Douglas W. House, SA News Editor3 Comments
  • Amgen (NASDAQ:AMGN) Q1 results ($M): Revenues: 5,554 (+1.6%); Product Sales: 5,343 (+2.8%).
  • Net Income: 2,311 (+11.6%); non-GAAP net income: 2,466 (+5.7%); EPS: 3.25 (+16.5%); non-GAAP EPS: $3.47 (+10.2%); cash flow ops: 2,727 (+14.3%).
  • Key product sales: Neulasta: 1,155 (-4.5%); Enbrel: 1,105 (-6.4%); Sensipar/Mimpara: 497 (+18.1%); Prolia: 494 (+16.2%); Repatha: 123 (+151.0%); Blincyto: 49 (+44.1%); Parsabiv: 41.
  • 2018 Guidance: Revenues: $21.9B - 22.8B from $21.8B - 22.8B; EPS: $11.30 - 12.28 from $11.18 - 12.36; non-GAAP EPS: $12.80 - 13.70 from $12.60 - 13.70.
  • Shares are up 1% after hours.

Recommended For You

About AMGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AMGN--
Amgen Inc.